Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This chapter presents an overview of the genetics of Parkinson's disease (PD). Parkinsonism is clinically characterized by the triad of tremor, rigidity, and bradykinesia. PD is the most common cause of Parkinsonism and the second most prevalent neurodegenerative disorder after Alzheimer's disease. Earlier, PD was thought to have no genetic basis, and epidemiological data appeared to support this view. Cross-sectional studies also suggested that either there is no genetic basis, or that it is only evident in early-onset PD. Differing disease concordance rates between monozygotic and dizygotic twins in longitudinal studies including those using 18F-dopa positron emission tomography support heritability in PD. Studies show that Parkin mutations usually occur either as homozygous or compound heterozygous mutations (with different mutations in both alleles). However, many have been reported in which, despite extensive screening, only one of the alleles appears to be mutated. This chapter starts with a discussion on genetics of familial Parkinson's disease and then explains the term Parkinsonism-plus genes. The chapter concludes with explaining sporadic PD, genetic associations, and familial genes.

Original publication





Book title

Parkinson's Disease: Molecular and Therapeutic Insights From Model Systems

Publication Date



9 - 33